-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: Actuate Therapeutics Announces FDA Clearance of IND for Oral Elraglusib and Strategic Initiatives to Advance the Elraglusib Development Program

Dow Jones·05/11/2026 11:00:00

Please log in to view news